Gland Pharma, LIC Housing Finance, Gujarat Energy, CAMS and Amber Enterprises India saw the highest mutual fund selling among smallcap stocks in August, according to Dolat Capital.
Bitcoin reclaimed $80,000 and Ethereum approached $2,620 as crypto markets recovered despite a hawkish Federal Reserve stance and uncertainty around the CLARITY Act. Improving risk sentiment, cooling oil prices and short liquidations supported the rebound, while ETF outflows, elevated rates and regulatory uncertainty remain key factors shaping the market outlook.
Bank of India Mutual Fund CIO Alok Singh sees scope for banks to re-rate as low NPAs, healthy returns and loan growth support fundamentals. He expects policy announcements and stronger business numbers to ease concerns around NIMs and FCNR flows, while capital goods, banking and metals could deliver stronger earnings momentum.
Everything you need to know to watch or stream tonight’s UFC 331 fight card, which is headlined by a flyweight title fight between Joshua Van and Alexandre Pantoja
Beauty brands can command eye-popping prices, whether they’re celebrity-founded and internet-famous or built around a doctor’s name. E.l.f. Beauty agreed to pay up to $1 billion for Hailey Bieber’s Rhode, Coty paid $600 million for 51% of Kylie Cosmetics, and Shiseido spent $450 million on Dr. Dennis Gross Skincare. Now Blackstone is testing whether a…
This week, the Gates Foundation announced a $1 billion commitment to build and deliver equitable AI tools to schools, frontline health care workers, farmers, and more. Of that commitment, 40% will go toward education, including AI tutoring to individualize learning in classrooms both in the U.S. and abroad. That’s a whopping $400 million infusion into…
Only two of 23 mutual fund themes, IPO and defence, gained in August as domestic equities faced broad-based pressure, according to Vallum Capital. Auto, railways and technology were among the biggest laggards, while equity fund inflows fell sharply. Commodities remained the strongest performer on a year-to-date basis despite a monthly decline.